Bevacizumab for the management of low-grade serous ovarian cancer in first-line and recurrent disease

被引：0
|
作者：
Van Den Kieboom, Natalia [1 ]
Ottenbourgs, Tine [2 ]
Van Nieuwenhuysen, Els [3 ,4 ]
机构：
[1] Katholieke Univ Leuven, Leuven Canc Inst, Dept Gynaecol & Obstet, Leuven, Belgium
[2] Katholieke Univ Leuven, Leuven Canc Inst, Lab Gynaecol Oncol, Leuven, Belgium
[3] Univ Hosp Leuven, Leuven, Belgium
[4] Luxembourg Gynaecol Oncol Grp BGOG, Leuven, Belgium
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2024年 / 34卷 / SUPPL_3期
关键词：
D O I：
10.1136/ijgc-2024-IGCS.457
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EV338/#101
引用
收藏
页码：A258 / A259
页数：2
相关论文
共 50 条
  • [21] Epidemiology of low-grade serous ovarian cancer - Discussion
    Greer, Benjamin E.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2008, 198 (04)
  • [22] Dual Fulvestrant-Trametinib Therapy in Recurrent Low-Grade Serous Ovarian Cancer
    Bussies, Parker L.
    Schlumbrecht, Matthew
    ONCOLOGIST, 2020, 25 (07): : E1124 - E1126
  • [23] Survival outcomes for patients with recurrent low-grade serous ovarian carcinoma
    Yazigi, A.
    Ray-Coquard, I. L.
    Pujade-Lauraine, E.
    Lecuru, F.
    Bonsang-Kitzis, H.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 93 - 94
  • [24] Low-grade Serous Ovarian Carcinoma
    Ricciardi, Enzo
    Baert, Thais
    Ataseven, Beyhan
    Heitz, Florian
    Prader, Sonia
    Bommert, Mareike
    Schneider, Stephanie
    du Bois, Andreas
    Harter, Philipp
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2018, 78 (10) : 972 - 976
  • [25] Bevacizumab in the First-line Treatment of advanced Ovarian Cancer
    Mallmann, Michael R.
    Alakus, Hakan
    Mallmann, Peter
    Bruns, Christiane
    ONKOLOGE, 2019, 25 (11): : 1020 - 1021
  • [26] BEVACIZUMAB FACILITATES SURGERY IN PREVIOUSLY INOPERABLE PATIENTS WITH LOW-GRADE SEROUS OVARIAN CANCER: A CASE SERIES
    Hockings, H.
    Wood, G.
    Lockley, M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A471 - A472
  • [27] Response to trametinib in recurrent low-grade serous ovarian cancer with NRAS mutation: A case report
    Champer, Miriam
    Miller, Devin
    Kuo, Dennis Yi-Shin
    GYNECOLOGIC ONCOLOGY REPORTS, 2019, 28 : 26 - 28
  • [28] Trametinib for patients with recurrent low-grade serous ovarian cancer: A cost-effectiveness analysis
    Piao, Huiling
    Wu, Meiyu
    Qin, Shuxia
    Tang, Zhiyao
    Zhou, Guangliang
    Wan, Xiaomin
    Zuo, Xiaocong
    GYNECOLOGIC ONCOLOGY, 2023, 168 : 17 - 22
  • [29] Redefining the Standard of Care for Low-Grade Serous Ovarian Cancer
    Manning-Geist, Beryl L.
    Cantor, Tal
    O'Cearbhaill, Roisin E.
    Grisham, Rachel N.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2024, 22 (05)
  • [30] Targeting BRAF pathway in low-grade serous ovarian cancer
    Perrone, Chiara
    Angioli, Roberto
    Luvero, Daniela
    Giannini, Andrea
    Di Donato, Violante
    Cuccu, Ilaria
    Muzii, Ludovico
    Raspagliesi, Francesco
    Bogani, Giorgio
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2024, 35 (04)
12345